| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dynamin 1 like | 0.475 | 0.808 | 5.7E-04 |
|
disease | 0.330 | strong | 1.000 | 3 | 0 | 2016 | 2019 | ||||||||
|
Ras homolog, mTORC1 binding | 0.631 | 0.577 | 0.98 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.894 | 47 | 3 | 1995 | 2019 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
disease | 0.100 | None | 1.000 | 17 | 1 | 1995 | 2018 | ||||||||
|
cyclin dependent kinase like 5 | 0.522 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 11 | 1 | 2008 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.090 | None | 1.000 | 9 | 1 | 2004 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 1 | 2004 | 2018 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2015 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.050 | None | 0.600 | 5 | 2 | 2008 | 2016 | ||||||||
|
major vault protein | 0.512 | 0.769 | 6.8E-08 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2003 | 2017 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 1998 | 2014 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
glial fibrillary acidic protein | 0.421 | 0.885 | 1.5E-06 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2006 | 2018 | ||||||||
|
solute carrier family 12 member 5 | 0.570 | 0.654 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2019 | ||||||||
|
solute carrier family 12 member 2 | 0.552 | 0.808 | 0.96 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2011 | 2018 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2011 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2018 | ||||||||
|
platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 0.504 | 0.769 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2017 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
EF-hand domain containing 1 | 0.659 | 0.231 | 1.9E-17 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2012 | 2012 | ||||||||
|
potassium sodium-activated channel subfamily T member 1 | 0.610 | 0.308 | 2.8E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 10 | 0.656 | 0.538 | 0.94 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2016 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2016 |